Get the Stockscreener App
7.09
6.71%
-0.51
After Hours:
7.09
Bioventus Inc Stock (BVS) Forecast
The Bioventus Inc (BVS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.5445, representing a -78.22% decrease from the current price of $7.09. The highest analyst price target is $2.5009, and the lowest is $0.5882.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BVS Price Target
Average 2.0575
(-70.98% Downside)
Is Bioventus Inc (BVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.65 | Neutral |
| STOCH(9,6) | 70.69 | Neutral |
| STOCHRSI(14) | 33.35 | Neutral |
| MACD(12,26) | 0.1052 | Sell |
| ADX(14) | 19.78 | Neutral |
| William %R | -53.38 | Neutral |
| CCI(14) | -5.2082 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
7.51
Sell
|
7.4188
Sell
|
| MA20 |
7.3805
Sell
|
7.3458
Sell
|
| MA50 |
7.0576
Buy
|
7.1844
Sell
|
| MA100 |
7.006
Buy
|
7.1787
Sell
|
| MA200 |
7.3958
Sell
|
7.7223
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, BVS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on BVS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.65 indicates that BVS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.69 indicates that BVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.35 indicates that BVS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.78 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -5.2082 indicates that BVS is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bioventus Inc financial reports and earnings history, Bioventus Inc (BVS) stock could reach $9.8461 by 2030, $26.61 by 2040 and $65.90 by 2050. See the projected annual prices until 2050 of the Bioventus Inc stock below:
- Bioventus Inc (BVS) is expected to reach an average price of $5.2356 in 2035, with a high prediction of $5.7375 and a low estimate of $5.7356. This indicates an $-26.15% rise from the last recorded price of $7.09.
- Bioventus Inc (BVS) stock is projected to chart a bullish course in 2040, with an average price target of $27.13, representing an $282.67% surge from its current level. The forecast ranges from a conservative $26.31 to a sky-high $26.61.
- Our analysts predict Bioventus Inc (BVS) to jump 328.74% by 2045, soaring from $30.68 to an average price of $30.40, potentially reaching $30.71. While $30.68 is the low estimate, the potential upside is significant.
- Bioventus Inc (BVS) stock is expected to climb by 2050, reaching an average of $63.75, a $799.20% jump from its current level. However, a wide range of estimates exists, with high and low targets of $65.90 and $64.06, respectively, highlighting the market's uncertainty.
Bioventus Inc Stock (BVS) Year by Year Forecast
Bioventus Inc Stock (BVS) Price Forecast for 2026
The predicted value for Bioventus Inc (BVS) in 2026 is set at an average of $2.0575. Estimates vary from a peak of $4.0897 to a trough of $0.0253, indicating an -70.98% surge from the present price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.6782 | $0.5882 | $2.5009 | -90.44% |
| February, 2026 | $0.4978 | $0.2678 | $2.0447 | -92.98% |
| March, 2026 | $0.6775 | $0.0253 | $1.0653 | -90.44% |
| April, 2026 | $4.2453 | $0.33 | $2.7053 | -40.12% |
| May, 2026 | $3.4156 | $3.8856 | $3.8131 | -51.82% |
| June, 2026 | $2.8959 | $3.2959 | $3.2308 | -59.15% |
| July, 2026 | $3.5588 | $3.6067 | $3.6013 | -49.80% |
| August, 2026 | $3.3791 | $3.9614 | $3.8166 | -52.34% |
| September, 2026 | $4.252 | $3.4517 | $3.9094 | -40.03% |
| October, 2026 | $4.1623 | $4.1972 | $4.0897 | -41.29% |
| November, 2026 | $2.1626 | $3.3226 | $4.0799 | -69.50% |
| December, 2026 | $1.8455 | $2.1355 | $2.0352 | -73.97% |
Bioventus Inc Stock (BVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bioventus Inc (BVS) is $1.4588, with a high forecast of $2.8911 and a low forecast of $0.0264. This indicates an -79.43% decrease from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.1858 | $1.5158 | $1.7907 | -83.27% |
| February, 2027 | $0.0161 | $1.131 | $0.961 | -99.77% |
| March, 2027 | $1.209 | $0.8687 | $0.729 | -82.95% |
| April, 2027 | $1.0693 | $1.2993 | $1.1074 | -84.92% |
| May, 2027 | $0.3196 | $0.7596 | $0.9744 | -95.49% |
| June, 2027 | $0.1375 | $0.0525 | $0.3575 | -98.06% |
| July, 2027 | $1.5172 | $0.0264 | $1.8302 | -78.60% |
| August, 2027 | $1.2369 | $1.0869 | $1.7746 | -82.55% |
| September, 2027 | $1.154 | $0.7743 | $1.4443 | -83.72% |
| October, 2027 | $2.1737 | $0.9415 | $2.5137 | -69.34% |
| November, 2027 | $1.9834 | $1.7411 | $2.8911 | -72.03% |
| December, 2027 | $1.607 | $0.9731 | $2.2408 | -77.33% |
Bioventus Inc Stock (BVS) Price Forecast for 2028
In 2028, Bioventus Inc (BVS) is projected to reach an average price of $3.7366, with a high projection of $6.3503 and a low estimate of $1.1229. This indicates an -47.30% fall from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.4255 | $6.40 | $6.3503 | -23.48% |
| February, 2028 | $4.2461 | $4.5061 | $4.0761 | -40.11% |
| March, 2028 | $4.4518 | $5.1318 | $4.3264 | -37.21% |
| April, 2028 | $0.7524 | $1.512 | $2.277 | -89.39% |
| May, 2028 | $1.9182 | $1.1229 | $1.4379 | -72.95% |
| June, 2028 | $2.5388 | $2.1087 | $1.6233 | -64.19% |
| July, 2028 | $2.6994 | $3.1941 | $2.4814 | -61.93% |
| August, 2028 | $2.7952 | $3.0049 | $2.6186 | -60.58% |
| September, 2028 | $3.5158 | $3.2903 | $2.9555 | -50.41% |
| October, 2028 | $1.0164 | $1.1864 | $1.7709 | -85.66% |
| November, 2028 | $3.3522 | $3.2015 | $3.8818 | -52.72% |
| December, 2028 | $1.9528 | $2.1628 | $2.9173 | -72.46% |
Bioventus Inc Stock (BVS) Price Forecast for 2029
The 2029 price forecast for Bioventus Inc Stock (BVS) is $5.1454 on average, with a high prediction of $8.8507 and a low estimate of $1.44. This represents an -27.43% decrease from the previous price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.4185 | $2.2631 | $2.7834 | -51.78% |
| February, 2029 | $2.5091 | $2.8791 | $2.9988 | -64.61% |
| March, 2029 | $2.1797 | $2.3944 | $1.4843 | -69.26% |
| April, 2029 | $1.9904 | $1.44 | $1.6504 | -71.93% |
| May, 2029 | $6.0761 | $2.5055 | $5.786 | -14.30% |
| June, 2029 | $5.1767 | $4.9964 | $4.8113 | -26.99% |
| July, 2029 | $6.8273 | $5.6919 | $6.8273 | -3.70% |
| August, 2029 | $4.6931 | $5.5881 | $5.8525 | -33.81% |
| September, 2029 | $5.9537 | $5.2834 | $5.4337 | -16.03% |
| October, 2029 | $5.8895 | $5.874 | $5.6689 | -16.93% |
| November, 2029 | $4.6901 | $5.9651 | $5.7098 | -33.85% |
| December, 2029 | $10.39 | $5.4218 | $8.8507 | +46.55% |
Bioventus Inc Stock (BVS) Price Forecast for 2030
Bioventus Inc Stock (BVS) is expected to reach an average price of $7.5545 in 2030, with a high forecast of $9.8461 and a low forecast of $5.2628. This signifies an +6.55% surge from the last price of $7.09.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.2564 | $9.4764 | $9.8461 | +30.56% |
| February, 2030 | $9.207 | $9.1419 | $9.1516 | +29.86% |
| March, 2030 | $9.2177 | $9.3527 | $9.2975 | +30.01% |
| April, 2030 | $8.8883 | $9.5683 | $9.3631 | +25.36% |
| May, 2030 | $9.574 | $8.9234 | $9.2689 | +35.04% |
| June, 2030 | $9.3346 | $9.3742 | $9.2995 | +31.66% |
| July, 2030 | $7.2654 | $7.3604 | $9.2148 | +2.47% |
| August, 2030 | $6.681 | $6.971 | $6.8555 | -5.77% |
| September, 2030 | $5.8716 | $6.2016 | $6.5513 | -17.18% |
| October, 2030 | $4.6174 | $5.3674 | $5.6068 | -34.87% |
| November, 2030 | $5.558 | $5.2628 | $5.0828 | -21.61% |
| December, 2030 | $5.2686 | $5.4986 | $5.3816 | -25.69% |
3.78%
0.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):